Digest Network Come funziona
Network
/
Società
Ag
Non verificato

Agenus Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieOncologiaSalute

54 comunicati stampa

Guarda tutti i comunicati
19/11/2025
Web e Social Network
Biotecnologia
Salute
Oncologia
Agenus to Host End-of-Year Stakeholder Webcast Featuring GI Oncology Leaders and Progress of BOT/BAL
Fonte
Agenus Inc.
Emittente
Business Wire
1.00
0
18/11/2025
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Medicina - Varie
Mercato del lavoro
Agenus Appoints Dr. José Iglesias as Chief Medical Affairs Officer to Guide Global Medical Affairs and Early-Access Programs, Including France’s AAC
Fonte
Agenus Inc.
Emittente
Business Wire
1.00
0
10/11/2025
Biotecnologia
HIV, AIDS e malattie autoimmuni
Salute
Medicina - Varie
Oncologia
Web e Social Network
Mercato azionario
Agenus Reports Q3 2025 Results Showcasing Clinical and Regulatory Advances
Fonte
Agenus Inc.
Emittente
Business Wire
1.00
0
05/11/2025
Web e Social Network
Finanza
Mercato azionario
Biotecnologia
Salute
Oncologia
Agenus to Provide Corporate Update and Third Quarter 2025 Financial Report
Fonte
Agenus Inc.
Emittente
Business Wire
1.00
0
17/10/2025
Biotecnologia
Salute
Oncologia
Eventi
Fiere
Industria
Agenus Reports 39% of Patients Alive at Two-Years with BOT/BAL Across Multiple Refractory Solid Tumors at ESMO 2025
Fonte
Agenus Inc.
Emittente
Business Wire
1.00
0
16/10/2025
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Web e Social Network
Agenus to Host October Stakeholder Briefing Showcasing BOT/BAL Global Momentum and Post-ESMO Insights
Fonte
Agenus Inc.
Emittente
Business Wire
1.00
0
09/09/2025
Scienza
Biotecnologia
Farmaceutica
Oncologia
Sanità
Salute
Medicina - Varie
Industria
France Grants Reimbursed Compassionate Access (AAC) for Agenus’ BOT/BAL in Refractory MSS Metastatic Colorectal Cancer
Fonte
Agenus Inc.
Emittente
Business Wire
1.00
0
26/08/2025
Biotecnologia
Salute
Oncologia
Medicina - Varie
Web e Social Network
Update: Agenus Aug 27 Stakeholder Webcast—Transformative IO Updates, BOT/BAL Data, BATTMAN Preview, Zydus Partnership Momentum, and MiNK Spotlight
Fonte
Agenus Inc.
Emittente
Business Wire
1.00
0
19/08/2025
Scienza
Biotecnologia
Farmaceutica
Oncologia
Sanità
Salute
Medicina - Varie
Web e Social Network
Telefonia e Varie
Industria
Agenus to Unveil BOT/BAL Strategic Advancements, Key Milestones, and Future Outlook in Virtual Stakeholder Briefing on August 27, 2025
Fonte
Agenus Inc.
Emittente
Business Wire
1.00
0
11/08/2025
Scienza
Biotecnologia
Farmaceutica
Oncologia
Sanità
Salute
Medicina - Varie
Web e Social Network
Telefonia e Varie
Mercato azionario
Agenus Announces Second Quarter 2025 Financial Results and Virtual Meeting to Discuss Strategic Progress
Fonte
Agenus Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0